HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

NuVasive Specialized Orthopedics Surpasses 100 Peer-Reviewed Publications of the Precice System for Limb Lengthening

NSO, a division of NuVasive, is focused on the design and innovation of disruptive orthopedic solutions for complex orthopedic reconstruction and limb lengthening.

MIVI Neuroscience Announces Multicenter Study of Aspiration Catheter in Combined Technique for Thrombus Removal

The AQUAS Registry is a prospective registry of 250 subjects conducted across up to 12 high-volume, comprehensive stroke centers in Europe reports MIVI Neuroscience .

Accelerate Diagnostics Announces New Data for Novel Accelerate Arc™ Module and BC Kit at ECCMID 2022

Accelerate Diagnostics advises latest data on automated path to rapid and accurate microbial identification of positive blood cultures using MALDI.

Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform

Virtual Incision notes the IDE supplement approval puts Virtual Incision on track to obtain the clinical evidence needed to bring innovation to the soft tissue surgical robotics industry.

Kardium Globe® Mapping and Ablation System Begins Clinical Trial at St. Paul’s Hospital

Kardium said Dr. Marc Deyell of St. Paul's Hospital is leading the study using the Globe System to navigate inside the heart and diagnose where the rhythm disturbances occur.

BIOTRONIK: BIO-LIBRA Initial Interim Analysis Results Demonstrate Higher Probability of Ventricular Tachyarrhythmias or Mortality in Men than Women

BIOTRONIK reports the results presented today show significant differences in one-year ventricular tachyarrhythmia or death rates by sex in patients with non-ischemic cardiomyopathy with an ICD or CRT-D.

Zio® by iRhythm Shown to Prevent Hospital Admissions, Aid in Early Detection of AF

Zio The new clinical evidence further validates the Zio service as a viable solution for the early detection of atrial fibrillation (AF),1 helping undiagnosed populations effectively seek treatment before more serious problems can occur.

ACC.22: Medtronic Renal Denervation System Demonstrates Significant BP Reduction Through 3 Years

ACC.22: Medtronic adds to its robust clinical program with long-term data demonstrating the continued blood pressure lowering effect of the Symplicity renal denervation procedure. Also completes enrollment in the SPYRAL HTN-ON MED trial.

Corvia Medical Reports: Reduce Lap-HF II Analyses Show 50% of Study Patients Demonstrated Significant Clinical Benefit from the Corvia Atrial Shunt

Corvia Medical notes in a large responder population, representing 50% of study patients, treatment with the Corvia® Atrial Shunt resulted in a 45% reduction in HF events and a 55% greater improvement in quality of life compared to sham control.